Inozyme Pharma stock target cut, maintains Buy rating April 9, 2024 by True Academy Comments are off Posted in:Stock Market & Investment NewsTagged with:Buy Sell ShareFTSEKLCIMalaysiaPelaburanSahamShare Trading See more Prev:Kaixin Auto Holdings rebrands to Kaixin Holdings Back: All Posts Next:Biora Therapeutics stock target cut, retains Buy rating